Lionel D'Hondt

Author PubWeight™ 8.44^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.	J Clin Oncol	2008	1.68
2	Clostridium tertium bacteremia: contamination or true pathogen? A report of two cases and a review of the literature.	Int J Infect Dis	2010	1.07
3	A systematic review of the predictive value of (18)FDG-PET in esophageal and esophagogastric junction cancer after neoadjuvant chemoradiation on the survival outcome stratification.	J Gastrointest Surg	2014	1.00
4	A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma.	Cancer Invest	2008	0.98
5	H2-mismatched transplantation with repetitive cell infusions and CD40 ligand antibody infusions without myeloablation.	Br J Haematol	2002	0.93
6	Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies.	Transfusion	2003	0.79
7	Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer.	Cancer Chemother Pharmacol	2012	0.78
8	Cyclin E in breast cancer.	N Engl J Med	2003	0.75
9	Stereotactic radiosurgery for the management of brain metastases.	N Engl J Med	2010	0.75